Insider · CIK 0001800110

Gayer Charles K

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001800110

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	President and CCO	MExercise/Conversion	+14.1K sh	$3.22	+$45.5K	892,492
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	President and CCO	MExercise/Conversion	+10.1K sh	$5.04	+$50.9K	902,583
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	President and CCO	MExercise/Conversion	+50K sh	$5.51	+$276K	952,583
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	President and CCO	MExercise/Conversion	−14.1K sh	—	—	0
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	President and CCO	MExercise/Conversion	−10.1K sh	—	—	17,409
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	President and CCO	MExercise/Conversion	−50K sh	—	—	0
2025-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−11.5K sh	$7.41	−$85K	878,350
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+471K sh	—	—	889,827
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+987K sh	—	—	986,950
2025-12-12	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−8,181 sh	$7.57	−$61.9K	418,827
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+126K sh	—	—	426,007
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−2,461 sh	$7.39	−$18.2K	423,546
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+261K sh	—	—	260,950
2024-12-14	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−8,251 sh	$7.53	−$62.1K	300,057
2024-05-13	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	President and CCO	PPurchase	+30K sh	$5.47	+$164K	307,533
2023-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−2,482 sh	$6.05	−$15K	274,533
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+34K sh	—	—	282,855
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	President and CCO	FTax Payment	−5,840 sh	$6.43	−$37.6K	277,015
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+159K sh	—	—	158,500
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+34K sh	—	—	245,610
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+159K sh	—	—	158,500
2022-12-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	President and CCO	SSale	−6,100 sh	$10.90	−$66.5K	211,610
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+125K sh	—	—	261,556
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+164K sh	—	—	164,000
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	President and CCO	AAward	+80K sh	—	—	216,556
2020-12-15	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	President and CCO	AAward	+190K sh	—	—	190,000

Recent filings

Accepted (ET)
Dec 234
Gayer Charles K0000882796-25-000041
SEC(opens sec.gov)
Dec 194
Gayer Charles K0001171843-25-008038
SEC(opens sec.gov)
Dec 164
Gayer Charles K0000882796-25-000036
SEC(opens sec.gov)
Dec 234
Gayer Charles K0001127602-24-029971
SEC(opens sec.gov)
Dec 174
Gayer Charles K0001127602-24-029602
SEC(opens sec.gov)
May 154
Gayer Charles K0001127602-24-015363
SEC(opens sec.gov)
Dec 204
Gayer Charles K0001127602-23-030185
SEC(opens sec.gov)
Dec 184
Gayer Charles K0001127602-23-029833
SEC(opens sec.gov)
Dec 214
Gayer Charles K0001127602-22-028076
SEC(opens sec.gov)

Companies

BIOCRYST PHARMACEUTICALS INCPresident and CCOBCRX

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703